Trial intelligence / Profile preview

Clindamycin vaginal ovule generic vs Dalacin for bacterial vaginosis

2016-004292-41Phase 3Completed

Sponsor
Verisfield
Start
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of clindamycin in bacterial vaginosis (BV), sponsored by Verisfield. Started Jan 2017; status: completed.

02

Drugs

clindamycin
03

Conditions

bacterial vaginosis (BV)

Beyond the preview

Go deeper on 2016-004292-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-004292-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call